                         SEQUENCE LISTING

<110>  The University Court of the University of Edinburgh
 
<120>  Optical Probe for Thrombin

<130>  P222831WO

<140>
<141>

<150>  GB 1504775.6
<151>  2015-03-20

<160>  38    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Gly Pro Lys Gly Leu Lys Gly 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Gly Pro Lys Gly Ile Lys Gly 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X = Nle

<400>  3

Gly Pro Lys Gly Xaa Lys Gly 
1               5           


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = bAla

<400>  4

Pro Phe Gly Met Lys Xaa 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = bAla

<400>  5

Pro Phe Gly Leu Lys Xaa 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = bAla

<400>  6

Pro Phe Gly Ile Lys Xaa 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = bAla

<400>  7

Pro Phe Gly Xaa Lys Xaa 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  8

Pro Xaa Gly Met Phe Gly 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = 3-cyclohexylalanine

<400>  9

Pro Xaa Gly Met Trp Gly 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = 3-cyclohexylalanine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X = 4-methoxyphenyl alanine

<400>  10

Pro Xaa Gly Met Xaa Gly 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = 3-cyclohexylalanine

<400>  11

Pro Xaa Gly Met Tyr Gly 
1               5       


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = 3-cyclohexylalanine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = bAla

<400>  12

Pro Xaa Gly Met Lys Xaa Gly 
1               5           


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = 3-cyclohexylalanine

<400>  13

Pro Xaa Gly Met His Gly 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = 3-cyclohexylalanine

<400>  14

Pro Xaa Gly Met Lys Gly 
1               5       


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Leu Trp Pro Arg Gly Trp Arg Leu 
1               5               


<210>  16
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  16

Leu Thr Pro Arg Gly Trp Arg Leu 
1               5               


<210>  17
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Ile Trp Pro Arg Gly Trp Arg Leu 
1               5               


<210>  18
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Ile Thr Arg Gly Trp Arg Leu 
1               5           


<210>  19
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<400>  19

Xaa Trp Pro Arg Gly Trp Arg Leu 
1               5               


<210>  20
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<400>  20

Xaa Thr Arg Gly Trp Arg Leu 
1               5           


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  21

Leu Trp Pro Arg Gly Trp Arg Xaa 
1               5               


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  22

Leu Thr Pro Arg Gly Trp Arg Xaa 
1               5               


<210>  23
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  23

Ile Trp Pro Arg Gly Trp Arg Xaa 
1               5               


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Leucine

<400>  24

Ile Thr Arg Gly Trp Arg Xaa 
1               5           


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  25

Xaa Trp Pro Arg Gly Trp Arg Xaa 
1               5               


<210>  26
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Leucine

<400>  26

Xaa Thr Arg Gly Trp Arg Xaa 
1               5           


<210>  27
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<400>  27

Leu Trp Pro Arg Gly Trp Xaa Leu 
1               5               


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<400>  28

Leu Thr Pro Arg Gly Trp Xaa Leu 
1               5               


<210>  29
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<400>  29

Ile Trp Pro Arg Gly Trp Xaa Leu 
1               5               


<210>  30
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<400>  30

Ile Thr Arg Gly Trp Xaa Leu 
1               5           


<210>  31
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<400>  31

Xaa Trp Pro Arg Gly Trp Xaa Leu 
1               5               


<210>  32
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = D-Arginine

<400>  32

Xaa Thr Arg Gly Trp Xaa Leu 
1               5           


<210>  33
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  33

Leu Trp Pro Arg Gly Trp Xaa Xaa 
1               5               


<210>  34
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Leucine

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  34

Leu Thr Pro Arg Gly Trp Xaa Xaa 
1               5               


<210>  35
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  35

Ile Trp Pro Arg Gly Trp Xaa Xaa 
1               5               


<210>  36
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Leucine

<400>  36

Ile Thr Arg Gly Trp Xaa Xaa 
1               5           


<210>  37
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X = D-Leucine

<400>  37

Xaa Trp Pro Arg Gly Trp Xaa Xaa 
1               5               


<210>  38
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X = Nle

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X = D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X = D-Leucine

<400>  38

Xaa Thr Arg Gly Trp Xaa Xaa 
1               5           


